BSEVivanza Biosciences LtdMinimalNeutral
Announced Thu, 9 Apr · 15:38 IST

Disclosure received from Promotor under Regulation 31(4) of SAST Reg, 2011 for the Year end 31st March, 2026.

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.5%1-day move
₹1.99
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+2.5+0.5+5.5+5.5+4.0-0.5+1.5+0.0-14.1-9.5
Up moveDown movePending
AI summary

Vivanza Biosciences Ltd has filed its annual promoter disclosure under SEBI's SAST regulations for the financial year ending 31 March 2026. Two promoters submitted their yearly declarations: Parth H. Parikh holding 79,07,622 shares and Hemant A. Parikh holding 1,00,211 shares as of 31 March 2026. Both promoters have confirmed they have not created any encumbrance (pledge) on their shares, either directly or indirectly, during the financial year. Jayendra Mehta also signed as Managing Director on the company's covering letter. This is a routine regulatory compliance filing required under SEBI regulations.

Likely market impact

This filing indicates stable promoter shareholding with no pledged shares, which is generally viewed positively by investors as it suggests promoters have not leveraged their holdings for loans or other purposes.